Prognostic significance of inflammatory biomarkers in diabetic and non-diabetic patients with STEMI, treated with primary percutaneous coronary intervention

Bibliographic Details
Title: Prognostic significance of inflammatory biomarkers in diabetic and non-diabetic patients with STEMI, treated with primary percutaneous coronary intervention
Authors: Milić Veljko, Džudović Boris, Obradović Slobodan
Source: Vojnosanitetski Pregled, Vol 76, Iss 10, Pp 979-984 (2019)
Publisher Information: Military Health Department, Ministry of Defance, Serbia, 2019.
Publication Year: 2019
Collection: LCC:Medicine (General)
Subject Terms: biomarkers, c-reactive protein, diabetes mellitus, fibrinogen, mortality, percutaneous coronary intervention, prognosis, st elevation myocardial infarction, Medicine (General), R5-920
More Details: Background/Aim. Although the prognostic significance of inflammatory biomarkers, C-reactive protein (CRP) and fibrinogen, in the patients with the ST-segment elevation myocardial infarction (STEMI) is already known, the specific difference between such patients according to diabetic status remains unknown. Methods. The study was conducted in a single tertiary center. The values of CRP and fibrinogen were measured during the first 48 h in consecutive patients with first STEMI treated with primary percutaneous coronary intervention (pPCI). The patients were divided into two groups: with diabetes and without diabetes. The aim of this study was to determine a prognostic significance of maximal values of these two inflammatory biomarkers for in-hospital and six-month mortality in these two groups. Results. Among 475 patients, 126 (26.5%) were with diabetes and 349 (73.5%) were without diabetes. The patients with diabetes had significantly higher median values of CRP and fibrinogen compared to the nondiabetic patients [29.6 (10.4–91.8) mg/L vs 22.4 (9.79–49.2) mg/L, p = 0.046 and 4.7 (3.6–6.3) g/L vs 4.3 (3.6–5.4) g/L, p = 0.026, respectively]. However, the multivariate survival analysis using the Cox regression model showed that in the nondiabetic STEMI patients CRP and fibrinogen had significant prognostic value for in-hospital mortality [hazard ratio (HR) = 1.013, 95% confidence interval (CI) (1.004–1.022), p = 0.004; HR = 1.529 (1.023–2.287), p = 0.039, respectively]. Regarding six-month mortality, no significant difference was achieved. Overall survival was the lowest in the fourth quartile of CRP in the patients without diabetes. Conclusion. The higher values of CRP are the significant independent predictor of in-hospital and overall mortality in the STEMI patients without diabetes treated with primary PCI. Fibrinogen can also be used as an additional prognostic inflammatory biomarker for in-hospital mortality in the non-diabetics with STEMI.
Document Type: article
File Description: electronic resource
Language: English
Serbian
ISSN: 0042-8450
2406-0720
Relation: https://doaj.org/toc/0042-8450; https://doaj.org/toc/2406-0720
DOI: 10.2298/VSP170905175M
Access URL: https://doaj.org/article/755c0f1276eb43228195bfb9853beeb9
Accession Number: edsdoj.755c0f1276eb43228195bfb9853beeb9
Database: Directory of Open Access Journals
FullText Links:
  – Type: pdflink
    Url: https://content.ebscohost.com/cds/retrieve?content=AQICAHjPtM4BHU3ZchRwgzYmadcigk49r9CVlbU7V5F6lgH7WwGk-WzogUNu6orXfSSOzMnjAAAA4jCB3wYJKoZIhvcNAQcGoIHRMIHOAgEAMIHIBgkqhkiG9w0BBwEwHgYJYIZIAWUDBAEuMBEEDCxniVXv9kdbm1jbqAIBEICBmj2TmWGzdkcfewaeeiFS7bonyu2sbZwww6RdnDdm7-l_I-3sK6DxMVBl-8ITcXv0_bSBsjSWiVau7a6J71ygUsAKm950DqhAh3VRLzYnolOcfbvE33cihdamR0RQA28QPzHCsHyZIO1hkGZ3s4ZRjiSlhN8SdZ7sckbXF_rUWUwTVBWg7DMfgwzGFQceQO5bRMReteuP8UDQq38=
Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=00428450&ISBN=&volume=76&issue=10&date=20190101&spage=979&pages=979-984&title=Vojnosanitetski Pregled&atitle=Prognostic%20significance%20of%20inflammatory%20biomarkers%20in%20diabetic%20and%20non-diabetic%20patients%20with%20STEMI%2C%20treated%20with%20primary%20percutaneous%20coronary%20intervention&aulast=Mili%C4%87%20Veljko&id=DOI:10.2298/VSP170905175M
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/755c0f1276eb43228195bfb9853beeb9
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.755c0f1276eb43228195bfb9853beeb9
RelevancyScore: 918
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 917.664306640625
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic significance of inflammatory biomarkers in diabetic and non-diabetic patients with STEMI, treated with primary percutaneous coronary intervention
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Milić+Veljko%22">Milić Veljko</searchLink><br /><searchLink fieldCode="AR" term="%22Džudović+Boris%22">Džudović Boris</searchLink><br /><searchLink fieldCode="AR" term="%22Obradović+Slobodan%22">Obradović Slobodan</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Vojnosanitetski Pregled, Vol 76, Iss 10, Pp 979-984 (2019)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Military Health Department, Ministry of Defance, Serbia, 2019.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2019
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Medicine (General)
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22biomarkers%22">biomarkers</searchLink><br /><searchLink fieldCode="DE" term="%22c-reactive+protein%22">c-reactive protein</searchLink><br /><searchLink fieldCode="DE" term="%22diabetes+mellitus%22">diabetes mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22fibrinogen%22">fibrinogen</searchLink><br /><searchLink fieldCode="DE" term="%22mortality%22">mortality</searchLink><br /><searchLink fieldCode="DE" term="%22percutaneous+coronary+intervention%22">percutaneous coronary intervention</searchLink><br /><searchLink fieldCode="DE" term="%22prognosis%22">prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22st+elevation+myocardial+infarction%22">st elevation myocardial infarction</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine+%28General%29%22">Medicine (General)</searchLink><br /><searchLink fieldCode="DE" term="%22R5-920%22">R5-920</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Background/Aim. Although the prognostic significance of inflammatory biomarkers, C-reactive protein (CRP) and fibrinogen, in the patients with the ST-segment elevation myocardial infarction (STEMI) is already known, the specific difference between such patients according to diabetic status remains unknown. Methods. The study was conducted in a single tertiary center. The values of CRP and fibrinogen were measured during the first 48 h in consecutive patients with first STEMI treated with primary percutaneous coronary intervention (pPCI). The patients were divided into two groups: with diabetes and without diabetes. The aim of this study was to determine a prognostic significance of maximal values of these two inflammatory biomarkers for in-hospital and six-month mortality in these two groups. Results. Among 475 patients, 126 (26.5%) were with diabetes and 349 (73.5%) were without diabetes. The patients with diabetes had significantly higher median values of CRP and fibrinogen compared to the nondiabetic patients [29.6 (10.4–91.8) mg/L vs 22.4 (9.79–49.2) mg/L, p = 0.046 and 4.7 (3.6–6.3) g/L vs 4.3 (3.6–5.4) g/L, p = 0.026, respectively]. However, the multivariate survival analysis using the Cox regression model showed that in the nondiabetic STEMI patients CRP and fibrinogen had significant prognostic value for in-hospital mortality [hazard ratio (HR) = 1.013, 95% confidence interval (CI) (1.004–1.022), p = 0.004; HR = 1.529 (1.023–2.287), p = 0.039, respectively]. Regarding six-month mortality, no significant difference was achieved. Overall survival was the lowest in the fourth quartile of CRP in the patients without diabetes. Conclusion. The higher values of CRP are the significant independent predictor of in-hospital and overall mortality in the STEMI patients without diabetes treated with primary PCI. Fibrinogen can also be used as an additional prognostic inflammatory biomarker for in-hospital mortality in the non-diabetics with STEMI.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English<br />Serbian
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 0042-8450<br />2406-0720
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://doaj.org/toc/0042-8450; https://doaj.org/toc/2406-0720
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.2298/VSP170905175M
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/755c0f1276eb43228195bfb9853beeb9" linkWindow="_blank">https://doaj.org/article/755c0f1276eb43228195bfb9853beeb9</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.755c0f1276eb43228195bfb9853beeb9
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.755c0f1276eb43228195bfb9853beeb9
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2298/VSP170905175M
    Languages:
      – Text: English
      – Text: Serbian
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 979
    Subjects:
      – SubjectFull: biomarkers
        Type: general
      – SubjectFull: c-reactive protein
        Type: general
      – SubjectFull: diabetes mellitus
        Type: general
      – SubjectFull: fibrinogen
        Type: general
      – SubjectFull: mortality
        Type: general
      – SubjectFull: percutaneous coronary intervention
        Type: general
      – SubjectFull: prognosis
        Type: general
      – SubjectFull: st elevation myocardial infarction
        Type: general
      – SubjectFull: Medicine (General)
        Type: general
      – SubjectFull: R5-920
        Type: general
    Titles:
      – TitleFull: Prognostic significance of inflammatory biomarkers in diabetic and non-diabetic patients with STEMI, treated with primary percutaneous coronary intervention
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Milić Veljko
      – PersonEntity:
          Name:
            NameFull: Džudović Boris
      – PersonEntity:
          Name:
            NameFull: Obradović Slobodan
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 00428450
            – Type: issn-print
              Value: 24060720
          Numbering:
            – Type: volume
              Value: 76
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Vojnosanitetski Pregled
              Type: main
ResultId 1